Contact the ACC Registration and Housing Center |
Learning Pathways
Explore the Program
ACC.25 features eleven learning pathways, each focusing on a different clinical specialty of cardiovascular disease. Choose to focus on one clinical area or attend sessions from an array of pathways.
Learn more about the sessions happening in each learning pathway.
The Cardiac Arrhythmias Learning Pathway will deliver practical guidance for managing common arrhythmias. From atrial fibrillation (AFib) management to device selection, all clinicians seeking to optimize patient care outcomes will gain confidence in handling the arrhythmia challenges they face daily.
The Cardiovascular Disease Prevention Learning Pathway will showcase the rapid evolution of preventive cardiology, from breakthrough therapeutics to innovative prevention strategies. Experts will help you master both foundational approaches and cutting-edge developments that are transforming cardiovascular risk reduction.
The Congenital Heart Disease (CHD) Learning Pathway will dive into the latest advances transforming pediatric and CHD care. Sessions will offer practical guidance for cardiovascular professionals committed to improving patient outcomes.
The Coronary, Peripheral and Structural Interventions Learning Pathway will cover a wide range of cutting-edge topics in interventional cardiology, including the management of cardiogenic shock, renal denervation for the management of hypertension, and the lifetime management of valvular heart disease. Whether you're interested in complex coronary disease, vascular medicine, or structural heart disease, this learning pathway will feature engaging sessions with expert faculty from around the globe.
The Heart Failure (HF) and Cardiomyopathies Learning Pathway will showcase the latest advances transforming the field of HF, from optimizing guideline-directed medical therapies to breakthrough developments in heart transplantation. Experts will deliver practical, evidence-based strategies for managing complex conditions, including cardiac amyloidosis and hypertrophic cardiomyopathy.
The Ischemic Heart Disease (IHD) Learning Pathway will tackle the most challenging aspects of IHD management, from everyday clinical decisions to complex scenarios that push the boundaries of what is currently understood. Experts will address critical questions about intervention timing vs. medical management, management of refractory symptoms, and optimal approaches to left main coronary artery disease (CAD).
The Multimodal Imaging Learning Pathway will showcase the essential role of advanced imaging in cardiovascular disease diagnosis and treatment. Through real-world clinical cases and expert-led discussions, the pathway will address both routine challenges and emerging innovations in cardiovascular imaging.
The Pulmonary Vascular Disease Learning Pathway offers comprehensive coverage of this rapidly evolving field, from foundational concepts to cutting-edge advances in pulmonary hypertension (PH), chronic thromboembolic pulmonary hypertension (CTEPH), and right ventricular failure management.
The Special Topics sessions will deliver essential updates on practice-changing developments while addressing crucial professional issues shaping the future of cardiovascular medicine.
The Valvular Diseases Learning Pathway will showcase the latest advances transforming valve disease management and equip you with the practical tools and emerging insights you need to improve patient outcomes. Experts will deliver practical and cutting-edge information on key topics, including contemporary management strategies, interdisciplinary care approaches and personalized therapeutics.
The Vascular Diseases Learning Pathway will offer attendees cutting-edge insights and practical knowledge in vascular medicine. This comprehensive learning pathway will feature expert-led sessions on critical topics in contemporary vascular care, including the latest peripheral artery disease (PAD) guidelines, innovations in hypertension management through renal denervation, and specialized care approaches for patients with end-stage renal disease on dialysis.
© 2024 American College of Cardiology Foundation. Visit ACC.org
Terms and Conditions • Registered User Agreement • Advertising and Sponsorship Policy • Privacy Policy • Cookie Policy • Contact Us